small molecule

OPTISON

ALBUMIN HUMAN

Loss of exclusivityMay 2028FDA regulatory exclusivity expiry
CompanyGE HEALTHCARE

Drug detail

Brand nameOPTISON
Active ingredientALBUMIN HUMAN
Strength10MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1997
Marketing statusRX

Regulatory exclusivity

CodeExpires
NPPMay 2028

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

OPTISON patent cliff — loss of exclusivity May 2028 | CliffBio